About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04042220

Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases

Background. Brain metastases are the most common intracranial tumor and occur in 20-40% of all oncological patients. The most common primary cancer in brain metastases is lung cancer, followed by mela...

Lead sponsor: Medical University of Vienna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Medical University of Vienna

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients, who were treated with Gamma Knife Radiosurgery for at least one or more brain metastases and diagnosed with one of two most common primary cancers (lung cancer or melanoma)
•Patients over 18 years and under 90 years
•Written, signed informed consent for study particaption after study explanation

Exclusion Criteria

•Patients under 18 years
•Patients over 90 years

Related studies

MeDex: No Perioperative Dexamethasone in Brain Metastases

NCT07044557 · Brain Metastases

RECRUITINGPhase 2

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

NCT05045950 · Brain Metastases

RECRUITINGPhase 2

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

NCT07462507 · Central Nervous System Cancer, Brain Metastases

RECRUITINGPhase 1

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more

RECRUITINGPhase 1/2

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

NCT05987644 · Lung Cancer, NSCLC, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 5, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment200

Start dateNov 2019

Last updatedJan 5, 2024

Condition

Brain Metastases

Locations shown

Department of Neurosurgery, Medical University of Vienna

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions